Related Reading Semaglutide Compounding Pharmacy Compounding Semaglutide Medvi Semaglutide Bioverse Semaglutide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
SURMOUNT-1 Trial (Jastreboff et al., 2022): Even at the 2.5 mg starting dose, participants achieved 16% weight loss
Chronic low-grade inflammation is now recognized as a root contributor to many modern health issues, including: Cardiovascular disease Autoimmune conditions Hormonal imbalance Metabolic dysfunction Accelerated aging GLP-1 receptors are present in immune cells, meaning GLPs can directly influence inflammatory pathways
The findings of the study revealed that semaglutide-treated participants continued to lose weight whereas those who switched to placebo did not see any discernible weight loss
Because the GLP-1 and GIP activity together strengthen blood sugar regulation, the medication connects directly to insulin resistance, a core driver of weight that will not move
Start with Part 1: Setting Realistic Weight Loss Expectations Nutrition Therapy for Side Effects GLP-1 therapy can be an immensely impactful class of medication for obesity treatment and improving metabolic healthbut it only works if you can tolerate it